Other PET-derived metrics were not predictive of outcomes.<h4>Conclusion</h4>Our findings highlight PSMA-TV as an independent predictor of treatment failure following definitive RT in PCa, supporting its potential role as a risk-stratifying biomarker, paving the way for individualized therapeutic strategies. This evidence concerns the gene FOLH1 and posterior cortical atrophy.